
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains to increase …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

